Cargando…

Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)

We compared the efficacy and safety of low-molecular-weight heparins (LMWHs) in patients with cancer who are at low risk of venous thromboembolism (VTE). Patients were treated by medical oncologists in Turkey at 15 sites, where they were enrolled and followed up for a period of 12 months. Due to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozaslan, Ersin, Ozkan, Metin, Cicin, Irfan, Benekli, Mustafa, Kocer, Murat, Uysal, Mukremin, Oksuzoglu, Berna, Isikdogan, Abdurrahman, Cubukcu, Erdem, Elkiran, Emin T., Dane, Faysal, Aliustaoglu, Mehmet, Sevinc, Alper, Karaoglu, Aziz, Ulas, Arife, Gokoz-Dogu, Gamze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714721/ https://www.ncbi.nlm.nih.gov/pubmed/29455568 http://dx.doi.org/10.1177/1076029617753538

Ejemplares similares

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia
por: Sevinç, Alper, et al.
Publicado: (2018)

Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population
por: Benekli, Mustafa, et al.
Publicado: (2014)

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study
por: Yalçın, Şuayib, et al.
Publicado: (2018)

Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?
por: Kucukoner, Mehmet, et al.
Publicado: (2012)

Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience
por: KEFELI, UMUT, et al.
Publicado: (2013)

Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival
por: Turkoz, Fatma Paksoy, et al.
Publicado: (2014)

A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer
por: Ulas, Arife, et al.
Publicado: (2014)

Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study
por: Yalcin, Suayib, et al.
Publicado: (2020)

COVID-19 and Diarrhoea: the Therapeutic Role OF LMWH
por: Dioscoridi, Lorenzo, et al.
Publicado: (2021)

Atrial Function in Patients with Breast Cancer After Treatment with Anthracyclines
por: Yaylali, Yalin Tolga, et al.
Publicado: (2016)

Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres
por: Motlekar, Nusrat, et al.
Publicado: (2009)

The Efficacy of Tripterygium Glycosides Combined with LMWH in Treatment of HSPN in Children
por: Jin, Yan, et al.
Publicado: (2021)

Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
por: Wei, Qingqing, et al.
Publicado: (2023)

Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of Medical Oncology)
por: İnal, Ali, et al.
Publicado: (2015)

Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology
por: Mehmet, Kucukoner, et al.
Publicado: (2014)

Continuous administration of LMWH in critical patients: a contribution to the monitoring of hemocoagulation
por: Stach, Z, et al.
Publicado: (2006)

Retrospective comparison of efficacy and safety of CAPOX and FOLFOX regimens as adjuvant treatment in patients with stage III colon cancer
por: Degirmencioglu, Serkan, et al.
Publicado: (2019)

A latent reactive handle for functionalising heparin-like and LMWH deca- and dodecasaccharides
por: Miller, Gavin J., et al.
Publicado: (2015)

Heparin‐induced hyperkalemia, can LMWH cause hyperkalemia? A systematic review
por: Amdetsion, Gedion Yilma, et al.
Publicado: (2023)

Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study
por: Dane, Faysal, et al.
Publicado: (2020)

Enhanced stability and efficacy of GEM-TOS prodrug by co-assembly with antimetastatic shell LMWH-TOS
por: Guo, Rong, et al.
Publicado: (2020)

The effectiveness and safety of LMWH for preventing thrombosis in patients with spinal cord injury: a meta-analysis
por: Lin, Ze, et al.
Publicado: (2021)

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
por: Elkiran, Emin T, et al.
Publicado: (2007)

Evaluation of hypermetabolic mediastinal-hilar lymph nodes determined by PET/CT with EBUS-TBNA and calculation of SUVmax cutoff values in differentiation of malignancy
por: Ugurlu, Erhan, et al.
Publicado: (2023)

Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children
por: Fiamoli, Veronika, et al.
Publicado: (2011)

Coumadin-induced skin necrosis in a 64 year-old female despite LMWH bridging therapy
por: Kumar, Mehandar, et al.
Publicado: (2012)

Pulmonary embolism caused by delayed heparin-induced thrombocytopenia in a patient who received prophylactic LMWH
por: Kumar, Mehandar, et al.
Publicado: (2012)

CLRM-03 INCIDENCE OF INTRACRANIAL HEMORRHAGE IN GLIOMA PATIENTS WITH VENOUS THROMBOEMBOLISM CONVERTED FROM LMWH TO APIXABAN
por: Aboud, Orwa, et al.
Publicado: (2022)

Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
por: Esbah, Onur, et al.
Publicado: (2017)

Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors?
por: Yildiz, Fatih, et al.
Publicado: (2020)

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit
por: Vlot, E.A., et al.
Publicado: (2020)

DOACs or VKAs or LMWH – What is the optimal regimen for cancer-associated venous thromboembolism? A systematic review and meta-analysis
por: Yamani, Naser, et al.
Publicado: (2022)

Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing?
por: Diepstraten, Jeroen, et al.
Publicado: (2022)

Thrombin Generation Decrease After LMWH Administration in an Antithrombin-Deficient Pregnant Woman With a Homozygous HBS II Mutation
por: Malikova, Ivana, et al.
Publicado: (2023)

De Novo Osteogenic Sarcoma of Mastoid Bone
por: Işikdogan, Abdurrahman, et al.
Publicado: (2002)

Bleeding Risk during Treatment of Acute Thrombotic Events with Subcutaneous LMWH Compared to Intravenous Unfractionated Heparin; A Systematic Review
por: Costantino, Giorgio, et al.
Publicado: (2012)

Differentiation of Tuberculous Peritonitis from Peritonitis Carcinomatosa without Surgical Intervention
por: Kaya, Muhsin, et al.
Publicado: (2011)

Tumor lysis syndrome during radiotherapy for prostate cancer with bone and bone marrow metastases without visceral metastasis
por: Kaplan, Muhammet Ali, et al.
Publicado: (2012)

The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy()
por: Desai, Antonio, et al.
Publicado: (2021)

MON-182 Increased Risk of Bleeding and Excessive Anticoagulation Using Standard Dose Low Molecular Weight Heparin (LMWH) in Cushing’s Syndrome
por: Haykal, Rasha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0mfpc1o0o0omqb194lkl52ad2s